Global Endocrine, Nutritional and Metabolic Diseases Mortality by Country

The data highlights the significant disparities in mortality rates from endocrine, nutritional, and metabolic diseases across countries. The United States leads with the highest mortality rate, followed by Mexico and Brazil. European countries like Germany and the UK have considerably lower rates, and the Nordic countries have the lowest rates globally. Recent trends from 2023 indicate increases in several countries, with Costa Rica, Colombia, and Croatia showing notable rises, whereas South Korea and Slovakia saw slight declines. The compound annual growth rate (CAGR) over the past five years indicates a consistent increase, especially in Peru, illustrating a concerning upward trend.

Future trends to watch include evolving healthcare policies, technological advancements, and lifestyle changes that may affect these mortality rates. Countries experiencing high growth rates in mortality might consider implementing public health interventions and innovations targeting prevention and better management of endocrine, nutritional, and metabolic diseases.

Top countries in Endocrine, Nutritional and Metabolic Diseases Mortality by Country

# 10 Countries Units (Male Deaths) Last Year YoY 5-years CAGR
1 1 United States 117,060 2023 +9.56% +10.65% View data
2 2 Mexico 78,330 2023 +4.22% +6.84% View data
3 3 Brazil 45,600 2023 +1.29% +3.77% View data
4 4 Germany 17,700 2023 +2.16% +2.62% View data
5 5 South Africa 14,000 2023 +1.13% +1.28% View data
6 6 Japan 12,140 2023 +0.97% +0.64% View data
7 7 Colombia 7,510 2023 +2.69% +8.96% View data
8 8 Peru 7,100 2023 +9.89% +13.8% View data
9 9 United Kingdom 6,940 2023 +4.22% +5.31% View data
10 10 Spain 6,860 2023 +0.99% +3.05% View data

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease